Efficacy evaluation of laparoscopy-assisted surgery for Siewert adenocarcinoma of the esophagogastric junction
10.3760/cma.j.issn.1671-0274.2014.05.017
- VernacularTitle:腹腔镜辅助手术治疗SiewertⅠ型食管胃结合部腺癌的疗效评价
- Author:
Weimin FANG
1
;
Yuanmei CHEN
;
Kunshou ZHU
Author Information
1. 福建省肿瘤医院胸外科
- Keywords:
Adenocarcinoma of the esophagngastric junction,Siewert typeⅠ;
Lymphadenectomy;
Laparoscopy;
Surgical approach
- From:
Chinese Journal of Gastrointestinal Surgery
2014;(5):476-479
- CountryChina
- Language:Chinese
-
Abstract:
Objective To evaluate the safety and efficacy of laparoscopy-assisted surgery for SiewertⅠadenocarcinoma of the esophagogastric junction(AEJ). Methods Clinical data of 36 patients who underwent left transthoracic dissection of lower mediastinal lymph node followed by laparoscopy D2 lymph node dissection for SiewertⅠAEJ in the Fujian Provincial Cancer Hospital between March 2008 and March 2013 were analyzed retrospectively. A left thoracic-abdominal single incision was used without transection of costal arch. Celiac lymph nodes dissection was performed laparoscopially followed by left transthoracic dissection of lower mediastinal lymph node. Digestive tract reconstruction was carried out by esophagus-gastric posterior wall end-to-side anastomosis. Results Laparoscopy-assisted surgery was successfully achieved in all the 36 patients and there were no in-hospital deaths. The mean operation time, blood loss and number of harvested lymph node were (216.4±46.0) min, (252.1±41.1) ml and 30.7±3.2 respectively. All the procedures were R0 resections. The complication rate was 16.7%(6/36). All the complications were managed by conservative treatment, and there were no re-operations. The lymphatic metastasis rate was 50.0%(18/36), and the lymph node groups with high metastatic rate (all> 10.0%) were groups 1, 2, 3, 7, 9, 110 and 111. The median follow-up was 25 months. The overall 3-year survival was 48.0%. Conclusion Laparoscopy-assisted surgery for SiewertⅠAEJ is safe and feasible.
